AgelessRx operates a telehealth platform delivering personalized longevity medicine treatments prescribed by US-licensed medical providers and sent directly to patients' homes. The platform offers evidence-based interventions targeting aging, including Metformin, NAD+, low-dose naltrexone, and GLP-1 support, alongside biological age testing to inform treatment decisions.
The company positions itself around preventive and functional medicine, drawing on current research into healthspan extension. Its model centres on making longevity science accessible through digital health infrastructure, with all prescriptions issued and monitored by licensed clinicians. AgelessRx advanced as a semi-finalist in the XPRIZE Healthspan competition, reflecting recognition in the longevity medicine space.
Clinical and operational teams work across the telehealth platform to deliver personalized care plans. The company serves patients across the United States through its online-based distribution model, eliminating geographical barriers to accessing these treatments.
